Skip to main content

Advertisement

SpringerLink
Log in

Immune Modulation with a Staphylococcal Preparation in Fibromyalgia/Chronic Fatigue Syndrome: Relation Between Antibody Levels and Clinical Improvement

  • Article
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The aims of this study were to evaluate the serological response to treatment with staphylococcal vaccine in fibromyalgia/chronic fatigue syndrome patients and to explore the relationship between serological response and clinical effect. Twenty-eight patients, half of whom served as controls, were recruited from a 6-month randomised trial in which repeated administration of the staphylococcal toxoid vaccine Staphypan Berna (Berna Biotech, Switzerland) was tested against placebo. Antibody status against extracellular toxins/enzymes, cell-wall components, and enterotoxins was evaluated at baseline and at endpoint. The clinical response to treatment was recorded in rating scales. In the group receiving active treatment, significant serological changes were recorded, whereas no significant changes were found in controls. Treatment led to a significantly increased capacity of serum to neutralise alpha-toxin and a significant increase in serum IgG to alpha-toxin and lipase. Furthermore, the increase in these parameters combined paralleled the improvement in clinical outcome. Thus, the greater the serological response, the greater was the clinical effect. In conclusion, this explorative study has shown that repeated administration of the Staphypan Berna vaccine in patients with fibromyalgia/chronic fatigue syndrome causes a serological response to several staphylococcal antigens, particularly to certain extracellular toxins and enzymes. The results further show that this response is related to the clinical outcome of treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Buchwald D, Garrity D (1994) Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. Arch Intern Med 154:2049–2053

    Article  CAS  PubMed  Google Scholar 

  2. Buchwald D (1996) Fibromyalgia and chronic fatigue syndrome: similarities and differences. Rheum Dis Clin North Am 22:219–243

    CAS  PubMed  Google Scholar 

  3. White KP, Speechley M, Harth M, Ostbye T (2000) Co-existence of chronic fatigue syndrome with fibromyalgia syndrome in the general population. A controlled study. Scand J Rheumatol 29:44–51

    Article  CAS  PubMed  Google Scholar 

  4. Aaron LA, Burke MM, Buchwald D (2000) Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med 160:221–227

    Article  CAS  PubMed  Google Scholar 

  5. Aaron LA, Herrell R, Ashton S, Belcourt M, Schmaling K, Goldberg J, Buchwald D (2001) Comorbid clinical conditions in chronic fatigue: a co-twin control study. J Gen Intern Med 16:24–31

    Google Scholar 

  6. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al. (1990) American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–172

    CAS  PubMed  Google Scholar 

  7. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A (1994) The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 121:953–959

    CAS  PubMed  Google Scholar 

  8. Buskila D, Press J, Gedalia A, Klein M, Neumann L, Boehm R, Sukenik S (1993) Assessment of nonarticular tenderness and prevalence of fibromyalgia in children. J Rheumatol 20:368–370

    CAS  PubMed  Google Scholar 

  9. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L (1995) The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38:19–28

    CAS  PubMed  Google Scholar 

  10. White KP, Speechley M, Harth M, Ostbye T (1999) The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol 26:1570–1576

    CAS  PubMed  Google Scholar 

  11. Wessely S, Chalder T, Hirsch S, Wallace P, Wright D (1997) The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. Am J Public Health 87:1449–1455

    CAS  PubMed  Google Scholar 

  12. Kawakami N, Iwata N, Fujihara S, Kitamura T (1998) Prevalence of chronic fatigue syndrome in a community population in Japan. Tohoku J Exp Med 186:33–41

    CAS  PubMed  Google Scholar 

  13. Jason LA, Richman JA, Rademaker AW, Jordan KM, Plioplys AV, Taylor RR, McCready W, Huang CF, Plioplys S (1999) A community-based study of chronic fatigue syndrome. Arch Intern Med 159:2129–2137

    Article  CAS  PubMed  Google Scholar 

  14. Goldenberg DL (1993) Do infections trigger fibromyalgia? Arthritis Rheum 36:1489–1492

    CAS  PubMed  Google Scholar 

  15. Goldenberg DL (1999) Fibromyalgia syndrome a decade later: what have we learned? Arch Intern Med 159:777–785

    CAS  PubMed  Google Scholar 

  16. Butt HL, Dunstan RH, McGregor NR, Roberts TK, Zerbes M, Klineberg IJ (1998) An association of membrane-damaging toxins from coagulase-negative staphylococci and chronic orofacial muscle pain. J Med Microbiol 47:577–584

    CAS  PubMed  Google Scholar 

  17. White PD, Thomas JM, Amess J, Crawford DH, Grover SA, Kangro HO, Clare AW (1998) Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br J Psychiatry 173:475–481

    CAS  PubMed  Google Scholar 

  18. Patarca-Montero R, Antoni M, Fletcher MA, Klimas NG (2001) Cytokine and other immunologic markers in chronic fatigue syndrome and their relation to neuropsychological factors. Appl Neuropsychol 8:51–64

    CAS  PubMed  Google Scholar 

  19. van West D, Maes M (2001) Neuroendocrine and immune aspects of fibromyalgia. BioDrugs 15:521–531

    PubMed  Google Scholar 

  20. Fleming A (1939) Recent advances in vaccine therapy. Br Med J 15:100–104

    Google Scholar 

  21. Dolman CE, Lond MRCP (1935) Clinical uses of staphylococcus toxoid. Lancet, Feb 9:306–313

    Google Scholar 

  22. Andersson M, Bagby JR, Dyrehag LE, Gottfries CG (1998) Effects of staphylococcus toxoid vaccine on pain and fatigue in patients with fibromyalgia/chronic fatigue syndrome. Eur J Pain 2:133–142

    PubMed  Google Scholar 

  23. Åsberg M, Montgomery SA, Perris C, Schalling D, Sedvall G (1978) A comprehensive psychopathological rating scale. Acta Psychiatr Scand 271 (Suppl):5–27

    PubMed  Google Scholar 

  24. Zachrisson O, Regland B, Jahreskog M, Jonsson M, Kron M, Gottfries CG (2002) Treatment with staphylococcus toxoid in fibromyalgia/chronic fatigue syndrome–a randomized controlled trial. Eur J Pain 6:455–466

    Article  CAS  PubMed  Google Scholar 

  25. Burckhardt CS, Clark SR, Bennett RM (1991) The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18:728–733

    CAS  PubMed  Google Scholar 

  26. Perris C (1979) Reliability and validity studies of the Comprehensive Psychopathological Rating Scale (CPRS). Prog Neuropsychopharmacol 3:413–421

    CAS  PubMed  Google Scholar 

  27. Kanclerski K, Soderquist B, Kjellgren M, Holmberg H, Möllby R (1996) Serum antibody response to Staphylococcus aureus enterotoxins and TSST-1 in patients with septicaemia. J Med Microbiol 44:171–177

    CAS  PubMed  Google Scholar 

  28. Möllby R (1983) Isolation and properties of membrane-damaging toxins. In: Easmon CSF, Adlam C (eds) Staphylococci and staphylococcal disease. Academic Press, London, ??

  29. Reizenstein E, Hallander HO, Blackwelder WC, Kuhn I, Ljungman M, Möllby R (1995) Comparison of five calculation modes for antibody ELISA procedures using pertussis serology as a model. J Immunol Methods 183:279–290

    Article  CAS  PubMed  Google Scholar 

  30. Colque-Navarro P, Soderquist B, Holmberg H, Blomqvist L, Olcen P, Möllby R (1998) Antibody response in Staphylococcus aureus septicaemia – a prospective study. J Med Microbiol 47:217–225

    CAS  PubMed  Google Scholar 

  31. Kanclerski K, Möllby R (1987) A simple and exact two-point interpolation method for determination of haemolytic activity in microtiter plates. Acta Pathol Microbiol Immunol Scand [B] 95:175–179

    Google Scholar 

  32. Julander IG, Granstrom M, Hedstrom SA, Möllby R (1983) The role of antibodies against alpha-toxin and teichoic acid in the diagnosis of staphylococcal infections. Infection 11:77–83

    CAS  PubMed  Google Scholar 

  33. Tyski S, Colque-Navarro P, Hryniewicz W, Granstrom M, Möllby R (1991) Lipase versus teichoic acid and alpha-toxin as antigen in an enzyme immunoassay for serological diagnosis of Staphylococcus aureus infections. Eur J Clin Microbiol Infect Dis 10:447–449

    CAS  PubMed  Google Scholar 

  34. Möllby R (1991) The antibody response in staphylococcal infections: diagnostic and therapeutic applications. The staphylococci. Zentralbl Bakteriol (Suppl) 21:61–68

    Google Scholar 

  35. Lee JC (2001) Development of antistaphylococcal vaccines. Curr Infect Dis Rep 3:517–524

    PubMed  Google Scholar 

  36. Söderquist B, Colque-Navarro P, Blomqvist L, Olcén P, Holmberg H, Möllby R (1993) Enzyme immunoassay for detection of alpha-toxin from Staphylococcus aureus. Serodiagn Immunother Infect Dis 5:23–26

    Google Scholar 

  37. Mudd S (1971) Resistance against Staphylococcus aureus. JAMA 218:1671–1673

    Article  CAS  PubMed  Google Scholar 

  38. Proctor RA, Kahl B, von Eiff C, Vaudaux PE, Lew DP, Peters G (1998) Staphylococcal small-colony variants have novel mechanisms for antibiotic resistance. Clin Infect Dis 27 (Suppl 1): 68–74

    PubMed  Google Scholar 

  39. von Eiff C, Proctor RA, Peters G (2000) Staphylococcus aureus small-colony variants: formation and clinical impact. Int J Clin Pract 115 (Suppl):44–49

    Google Scholar 

  40. Tarello W (2001) Chronic fatigue syndrome (CFS) associated with Staphylococcus spp. bacteremia, responsive to potassium arsenite 0.5% in a veterinary surgeon and his coworking wife, handling with CFS animal cases. Comp Immunol Microbiol Infect Dis 24:233–246

    Article  CAS  PubMed  Google Scholar 

  41. Hume EB, Dajcs JJ, Moreau JM, O’Callaghan RJ (2000) Immunization with alpha-toxin toxoid protects the cornea against tissue damage during experimental Staphylococcus aureus keratitis. Infect Immun 68:6052–6055

    Article  CAS  PubMed  Google Scholar 

  42. Dean JH, Silva JS, McCoy JL, Chan SP, Baker JJ, Leonard C, Herberman RB (1975) In vitro human reactivity to staphylococcal phage lysate. J Immunol 115:1060–1064

    CAS  PubMed  Google Scholar 

  43. Krishan G, et al (1994) Cytokines produced by Staphage Lysate. In: Program and abstracts of the 12th European Immunology Meeting, Barcelona, Spain, Abstract no. A123/C/00115

  44. Shayegani M, Parsons LM, Maupin PS (1980) Correlation of staphylococci-induced delayed-type hypersensitivity and nonspecific resistance during their development, long-term duration and adoptive transfer. J Reticuloendothel Soc 28:265–274

    CAS  PubMed  Google Scholar 

  45. Nilsson IM, Verdrengh M, Ulrich RG, Bavari S, Tarkowski A (1999) Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity. J Infect Dis 180:1370–1373

    Article  CAS  PubMed  Google Scholar 

  46. Christensson B, Hedstrom SA (1985) Serological response to toxic shock syndrome toxin in Staphylococcus aureus infected patients and healthy controls. Acta Pathol Microbiol Immunol Scand [B] 93:87–90

    Google Scholar 

  47. Nordin U, Wannfors K, Colque-Navarro P, Mollby R, Heimdahl A (1995) Antibody response in patients with osteomyelitis of the mandible. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79:429–435

    CAS  PubMed  Google Scholar 

  48. Gupta S, Vayuvegula B (1991) A comprehensive immunological analysis in chronic fatigue syndrome. Scand J Immunol 33:319–327

    CAS  PubMed  Google Scholar 

  49. Regland B, Zachrisson O, Stejskal V, Gottfries CG (2001) Nickel allergy is found in a majority of women with chronic fatigue syndrome and muscle pain – and may be triggered by cigarette smoke and dietary nickel intake. J Chronic Fatigue Syndr 8:57–65

    Google Scholar 

  50. Borg L, Christensen JM, Kristiansen J, Nielsen NH, Menne T, Poulsen LK (2000) Nickel-induced cytokine production from mononuclear cells in nickel-sensitive individuals and controls. Cytokine profiles in nickel-sensitive individuals with nickel allergy-related hand eczema before and after nickel challenge. Arch Dermatol Res 292:285–291

    CAS  PubMed  Google Scholar 

  51. Straus SE, Dale JK, Wright R, Metcalfe DD (1988) Allergy and the chronic fatigue syndrome. J Allergy Clin Immunol 81:791–795

    CAS  PubMed  Google Scholar 

  52. Benson M, Strannegard IL, Wennergren G, Strannegard O (2000) Low levels of interferon-gamma in nasal fluid accompany raised levels of T-helper 2 cytokines in children with ongoing allergic rhinitis. Pediatr Allergy Immunol 11:20–28

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The trial was conducted in accordance with the Declaration of Helsinki after approval by the local ethics committee.

Author information

Authors and Affiliations

  1. Institute of Clinical Neuroscience, SU/Mölndal, 431 80, Mölndal, Sweden

    O. Zachrisson, C. G. Gottfries & B. Regland

  2. Microbiology and Tumorbiology Center, Karolinska Institutet, Theorellvägen 3, 171 77, Stockholm, Sweden

    P. Colque-Navarro & R. Möllby

Authors
  1. O. Zachrisson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Colque-Navarro
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. G. Gottfries
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Regland
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Möllby
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to O. Zachrisson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zachrisson, O., Colque-Navarro, P., Gottfries, C.G. et al. Immune Modulation with a Staphylococcal Preparation in Fibromyalgia/Chronic Fatigue Syndrome: Relation Between Antibody Levels and Clinical Improvement. Eur J Clin Microbiol Infect Dis 23, 98–105 (2004). https://doi.org/10.1007/s10096-003-1062-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-003-1062-8

Keywords

Search

Navigation